Advertisement

© 2013

T-Cell Lymphomas

  • Francine Foss
Book

Part of the Contemporary Hematology book series (CH)

Table of contents

  1. Front Matter
    Pages i-xv
  2. Claudiu V. Cotta, Eric D. Hsi
    Pages 1-24
  3. Sophia S. Wang, Julie M. Vose
    Pages 25-39
  4. Pier Paolo Piccaluga, Stefano Aldo Pileri
    Pages 41-56
  5. Laurence de Leval, Francine Foss, Philippe Gaulard
    Pages 57-69
  6. Motoko Yamaguchi, Kensei Tobinai
    Pages 87-103
  7. Frederick Lansigan, S. David Hudnall, Francine Foss
    Pages 105-112
  8. Kunihiro Tsukasaki, Kensei Tobinai
    Pages 113-135
  9. Elisabeth Grey-Davies, Claire Dearden
    Pages 137-153
  10. Farah Rukhsana Abdulla, Madeleine Duvic, Youn H. Kim
    Pages 155-177
  11. Nader Kim El-Mallawany, Pieter Van Vlierberghe, Adolfo A. Ferrando, Megan S. Lim, Mitchell S. Cairo
    Pages 179-216
  12. David Sibon, Christian Gisselbrecht, Francine Foss
    Pages 217-228
  13. José Rodríguez, Paolo Corradini
    Pages 229-242
  14. Lapo Alinari, Pierluigi Porcu, Bertrand Coiffier
    Pages 243-261
  15. Varsha Gandhi, Pier Luigi Zinzani
    Pages 263-278
  16. Michael Dickinson, Chan Cheah, H. Miles Prince
    Pages 279-296
  17. Christiane Querfeld, Steven T. Rosen
    Pages 297-305
  18. Badri Modi, Francine Foss, Richard L. Edelson, Michael Girardi
    Pages 307-316
  19. Merry Jennifer Markham, Nam H. Dang
    Pages 317-331

About this book

Introduction

The mature T and NK cell lymphomas are rare, comprising approximately 10% of all malignant lymphomas. The incidence of T-cell lymphoma is variable around the world, with a higher incidence compared to B-cell lymphomas in the Asian basin. While the overall incidence of B-cell lymphomas has begun to decline in the United States, the incidence of T-cell lymphomas continues to rise. Over the last decade, a number of novel agents have been developed which target T-cell lymphomas and studies have identified novel genes and pathways associated with lymphomagenesis in T-cells.

 

This comprehensive volume examines the clinical and biological aspects of the T-cell lymphoproliferative disorders in adults and children. The book includes an overview of both the cutaneous and the systemic T-cell malignancies and addresses the classification of T-cell lymphomas, the clinical features of each subtype, and the relevant molecular and genetic studies. Clinical outcomes and treatment strategies are discussed with an emphasis on the development of novel biological and targeted therapies. An outstanding resource for hematologists and oncologists, this book gathers insights from experts in the field and provides the most up-to-date information on all of the T-cell lymphoma subgroups and current and emerging therapies.

Keywords

Blood Cancer Hematology Lymphoma Non-Hodgkin's Lymphoma Oncology T-cell

Editors and affiliations

  • Francine Foss
    • 1
  1. 1.Yale University School of MedicineDept. of Medical Oncology/HematologyNew HavenUSA

Bibliographic information

  • Book Title T-Cell Lymphomas
  • Editors Francine Foss
  • Series Title Contemporary Hematology
  • DOI https://doi.org/10.1007/978-1-62703-170-7
  • Copyright Information Springer Science+Business Media New York 2013
  • Publisher Name Humana Press, Totowa, NJ
  • eBook Packages Medicine Medicine (R0)
  • Hardcover ISBN 978-1-62703-169-1
  • Softcover ISBN 978-1-4939-5732-3
  • eBook ISBN 978-1-62703-170-7
  • Edition Number 1
  • Number of Pages XV, 340
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Hematology
    Oncology
    Angiology
  • Buy this book on publisher's site
Industry Sectors
Biotechnology
Health & Hospitals
Oncology & Hematology
Pharma

Reviews

From the reviews:

“This is a thorough review of the current knowledge about T-cell lymphomas, from basic science to clinical aspects. … The purpose is to thoroughly review the sum of knowledge of this set of diseases, one which has been met well. The book is most appropriate for residents, oncology/hematology fellows, and practicing oncologists, and can be a good reference for those who specialize in hematologic malignancies.” (Adam M. Petrich, Doody’s Book Reviews, September, 2013)